Skip to content

RIDASCREEN® α1-Antitrypsin

by R-Biopharm AG Germany EUDAMED

Ref G09034C04-VK EMDN W0102019002

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number4049095G090340000RW Basic UDI-DIDate20 Sep 2024RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
RIDASCREEN® α1-Antitrypsin
Model / Reference
G09034C04-VK
Primary DI / UDI-DI
04049095070006
Basic UDI-DI
4049095G090340000RW
EMDN Code
W0102019002 A1-antitrypsin (protease inhibitor)
Device Class
Class B
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
DE-MF-000007993

Other devices from R-Biopharm AG

See all devices from R-Biopharm AG →

Properties & raw data

Show properties, registry sources and raw records
  • Human Tissues
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (1)

  • EUDAMED 75b835ed-fa3c-4cfe-86f9-70668a0cfe09 61 fields · synced 22 Oct 2026